...
首页> 外文期刊>Rheumatology >Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors alpha and beta: correlation with methotrexate efficacy in rheumatoid arthritis patients.
【24h】

Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors alpha and beta: correlation with methotrexate efficacy in rheumatoid arthritis patients.

机译:甲氨蝶呤对糖皮质激素受体α和β的翻译同工型表达的影响:类风湿关节炎患者甲氨蝶呤疗效的相关性。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: To test the effect of MTX on the expression of glucocorticoid receptor (GR) alpha and beta isoforms AB, C and D in peripheral blood mononuclear cells (PBMCs) in culture, from newly diagnosed RA patients and to evaluate whether the test results correlate with patients' subsequent response to MTX treatment. METHODS: Twenty patients with early active RA were enrolled. Patients who had previously received any DMARD or cytotoxic agent, or who had received CSs in the 6 months before enrolment were excluded. PBMCs from all patients were obtained and cultured in the presence and absence of MTX (10(-4), 10(-6) and 10(-8) M). The expression of GR isoforms was evaluated by western blot. After blood samples were taken, patients entered a 24-week study receiving MTX, diclofenac and prednisone (10 mg/day). At Week 24, the ACR core set of disease activity measures was calculated and a correlation between the MTX effect on patients' PBMC GR expression in vitro and the ACR response was evaluated. RESULTS: MTX 10(-6) M in the culture medium induced the expression of the PBMC isoform AB of GRalpha (P = 0.009). Other GR isoforms were unaffected. The magnitude of the induced expression correlated with the ACR response to treatment at Week 24 of therapy (r = 0.92, P = 0.00003). CONCLUSION: MTX in vitro induces greater expression of GRalphaAB isoform in PBMC from RA patients who later respond to MTX treatment than in non-responding patients. This may have clinical applications for predicting MTX efficacy in RA patients.
机译:目的:测试MTX对新诊断RA患者培养的外周血单个核细胞(PBMC)中糖皮质激素受体(GR)α和β亚型AB,C和D表达的影响,并评估测试结果是否相关患者对MTX治疗的后续反应。方法:20例早期活动性RA患者入选。排除了之前曾接受过DMARD或细胞毒剂或在入组前6个月内曾接受过CS的患者。从所有患者中获得PBMC,并在存在和不存在MTX(10(-4),10(-6)和10(-8)M)的情况下进行培养。通过蛋白质印迹评估GR同工型的表达。采集血液样本后,患者接受MTX,双氯芬酸和泼尼松(10毫克/天)进行为期24周的研究。在第24周时,计算了ACR核心疾病活动度量标准,并评估了MTX对患者PBMC GR表达的体外影响与ACR反应之间的相关性。结果:MTX 10(-6)M在培养基中诱导了GRalpha的PBMC亚型AB的表达(P = 0.009)。其他GR同工型不受影响。在治疗的第24周,诱导表达的大小与ACR对治疗的反应相关(r = 0.92,P = 0.00003)。结论:MTX较不应答的RA患者在对MTX应答较晚的RA患者的PBMC中诱导了更大的GRalphaAB亚型表达。这可能具有预测RA患者MTX疗效的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号